Baofa Cancer Hospital Jinan

Baofa Cancer Hospital is a specialized oncology healthcare provider based in Jinan, China, founded by Dr. Yu Baofa. The hospital is distinguished by its development and clinical application of Ultra-minimum Incision Personalized Intratumoral Chemotherapy (UMIPIC), a technique often described as chemical surgery. This method involves the precise, image-guided injection of a personalized cocktail of chemotherapeutic drugs and haptens directly into solid tumors to induce tumor necrosis and stimulate a systemic immune response. By focusing on high local drug concentrations, the hospital aims to treat advanced-stage cancers while significantly reducing the side effects typically associated with systemic chemotherapy. Baofa Cancer Hospital operates several facilities across China and has gained international attention for its innovative approach to refractory malignancies. The institution's methodology effectively transforms the patient's own tumor into an in-situ vaccine, promoting long-term anti-tumor immunity.